BioPharmSignal logoBioPharmSignal

Biotech News

Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Arcutis Biotherapeutics (ARQT)Arcutis BiotherapeuticsConference / presentation

WESTLAKE VILLAGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the Morgan Stanley 24

Related news

ARQTArcutis Biotherapeutics2026-03-31 20:00 EST

Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference

ARQTArcutis Biotherapeutics2026-05-26 20:00 EST

Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference

View all latest news

Arcutis Biotherapeutics

Medical Dermatology Arcutis Biotherapeutics develops and commercializes targeted therapies for immune-mediated skin diseases, emphasizing convenient topical formulations against validated biology. ZORYVE Franchise ZORYVE is a once-daily topical roflumilast product available in cream and foam formulations across plaque psoriasis, atopic...

Recent company news

ARQTArcutis Biotherapeutics2026-10-02 20:00 EST

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ARQTArcutis Biotherapeutics2026-09-29 13:15 EST

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options

ARQTArcutis Biotherapeutics2026-09-04 20:00 EST

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ARQTArcutis Biotherapeutics2026-09-02 20:00 EST

Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

ARQTArcutis Biotherapeutics2026-08-07 20:00 EST

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Stock data

Close
25.29 USD
Market cap
2.6B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States